Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure.

Michele CorrealePietro MazzeoAdriana MallardiAlessandra LeopizziLucia TricaricoMartino FortunatoMichele MagnesaSalvatore TucciPasquale MaiellaroGiuseppe PastoreOlga LamacchiaMassimo IacovielloMatteo Di BiaseNatale Daniele Brunetti

Published in: Cardiovascular drugs and therapy (2021)

Switch to SGLT2i in patients with CHF and T2DM was associated in an observational non-randomized study with an improved endothelial function.

Keyphrases

type diabetes
ejection fraction
wound healing
glycemic control
adipose tissue